A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.
暂无分享,去创建一个
A Zelent | J. Licht | A. Melnick | A. Zelent | H. Ball | G. Owen | M. Hoatlin | S. Arai | Helen L. Ball | M E Hoatlin | Y Zhi | H Ball | K Silvey | A Melnick | S Stone | S Arai | N Hawe | G Owen | J D Licht | N. Hawe | Y. Zhi | K. Silvey | S. Stone | Sally Arai | K. V. Silvey | Gareth I. Owen
[1] J. Licht,et al. Sequence-specific DNA Binding and Transcriptional Regulation by the Promyelocytic Leukemia Zinc Finger Protein* , 1997, The Journal of Biological Chemistry.
[2] D. Näf,et al. The Fanconi anaemia proteins, FAA and FAC interact to form a nuclear complex , 1997, Nature Genetics.
[3] K. Borden,et al. Two RING Finger Proteins, the Oncoprotein PML and the Arenavirus Z Protein, Colocalize with the Nuclear Fraction of the Ribosomal P Proteins , 1998, Journal of Virology.
[4] A. D’Andrea,et al. Nuclear localization of the Fanconi anemia protein FANCC is required for functional activity. , 1999, Blood.
[5] H. Youssoufian. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] V. Oi. Immunoglobulin producing hybrid cell lines , 1980 .
[7] Chi-Wai Wong,et al. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein , 1998, Oncogene.
[8] A. Zelent,et al. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. , 1998, Blood.
[9] Johnson M Liu,et al. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. , 1998, Blood.
[10] A. D’Andrea,et al. The Fanconi anemia polypeptide FACC is localized to the cytoplasm. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] N. Aoki,et al. Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. , 1994, Blood.
[12] M. Buchwald,et al. Molecular and Cellular Biology of Fanconi Anemia , 1992, The American journal of pediatric hematology/oncology.
[13] G. Privé,et al. Crystal structure of the BTB domain from PLZF. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Licht,et al. The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis , 1998, Molecular and Cellular Biology.
[15] G. Privé,et al. The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Rowley,et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[17] Jonathan D. Licht,et al. Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .
[18] M. Privalsky,et al. Retinoid Isomers Differ in the Ability to Induce Release of SMRT Corepressor from Retinoic Acid Receptor-α* , 1999, The Journal of Biological Chemistry.
[19] S. Baylin,et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 , 1995, Nature Genetics.
[20] Hans Joenje,et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA , 1996, Nature Genetics.
[21] R. Marmorstein,et al. Overexpression, Purification, Characterization, and Crystallization of the BTB/POZ Domain from the PLZF Oncoprotein* , 1997, The Journal of Biological Chemistry.
[22] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[23] P. Pandolfi,et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation , 1997, Nature Genetics.
[24] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[25] V. Michels,et al. The Genetic Basis of Human Cancer , 1999 .
[26] M. Buchwald,et al. Fanconi anemia and novel strategies for therapy. , 1994, Blood.
[27] R. Espinosa,et al. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] Q. Waisfisz,et al. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] K. Kinzler,et al. Cancer-susceptibility genes. Gatekeepers and caretakers. , 1997, Nature.
[30] S. Elledge,et al. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. , 1993, Genes & development.
[31] D. Näf,et al. Functional Activity of the Fanconi Anemia Protein FAA Requires FAC Binding and Nuclear Localization , 1998, Molecular and Cellular Biology.
[32] D. Näf,et al. Fanconi Anemia Proteins FANCA, FANCC, and FANCG/XRCC9 Interact in a Functional Nuclear Complex , 1999, Molecular and Cellular Biology.
[33] C. Mathew,et al. The Fanconi anemia group E gene, FANCE, maps to chromosome 6p. , 1999, American journal of human genetics.
[34] L. Szekely,et al. The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein , 1998, Molecular and Cellular Biology.
[35] K. Schughart,et al. Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome. , 1999, Human molecular genetics.
[36] R. Gibson,et al. A common mutation in the FACC gene causes Fanconi anaemia in Ashkenazi Jews , 1993, Nature Genetics.
[37] E. Dmitrovsky,et al. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A , 1999, Oncogene.
[38] C. Tribioli,et al. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. , 1998, Nature genetics.
[39] Albert B. Reynolds,et al. The Catenin p120ctnInteracts with Kaiso, a Novel BTB/POZ Domain Zinc Finger Transcription Factor , 1999, Molecular and Cellular Biology.
[40] H. Alder,et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.
[41] P. Tiollais,et al. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain. , 1997, Oncogene.
[42] M. Buchwald,et al. Evidence for at least eight Fanconi anemia genes. , 1997, American journal of human genetics.
[43] E. Craig,et al. Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. , 1996, Genetics.
[44] R. Moses,et al. The Ashkenazi Jewish Fanconi anemia mutation: Incidence among patients and carrier frequency in the at‐risk population , 1994, Human mutation.
[45] M. Privalsky,et al. Components of the SMRT Corepressor Complex Exhibit Distinctive Interactions with the POZ Domain Oncoproteins PLZF, PLZF-RARα, and BCL-6* , 1998, The Journal of Biological Chemistry.
[46] A D Auerbach,et al. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. , 1997, Blood.
[47] M. Heinrich,et al. The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells. , 1998, Blood.
[48] S. Kajigaya,et al. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. , 1998, Blood.
[49] A. Dejean,et al. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[50] W. R. Shannon,et al. Cloning of cDNAs for Fanconi's anaemia by functional complementation , 1992, Nature.
[51] C. Mathew,et al. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation. , 1999, Experimental hematology.
[52] D. Leprince,et al. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene , 1999, Oncogene.
[53] Yonghong Xiao,et al. Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.
[54] H. Joenje,et al. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant , 1996, Human Genetics.
[55] J. Licht,et al. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[56] A. Zelent,et al. Fusion between a novel Krüppel‐like zinc finger gene and the retinoic acid receptor‐alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. , 1993, The EMBO journal.
[57] R. Berger,et al. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. , 1993, The Journal of clinical investigation.
[58] R. Gale,et al. Hematologic Abnormalities in Fanconi Anemia: An International Fanconi Anemia Registry Study , 1994 .
[59] A. D’Andrea,et al. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. , 1997, Blood.
[60] D. Leprince,et al. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo. , 1995, Oncogene.
[61] Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor. , 1998, Molecular endocrinology.
[62] N. Andrews,et al. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.
[63] M. Privalsky,et al. Transcriptional Repression by the SMRT-mSin3 Corepressor: Multiple Interactions, Multiple Mechanisms, and a Potential Role for TFIIB , 1998, Molecular and Cellular Biology.
[64] J M Davies,et al. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[65] K Offit,et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. , 1993, Science.
[66] Hans Joenje,et al. The Fanconi anaemia group G gene FANCG is identical with XRCC9 , 1998, Nature Genetics.
[67] G. Fanconi. Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects. , 1967, Seminars in hematology.
[68] S. Latt,et al. Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment. , 2005, Cytometry.
[69] J. Licht,et al. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. , 1996, Oncogene.
[70] L. Staudt,et al. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. , 1997, Science.
[71] M. Buchwald. Complementation groups: one or more per gene? , 1995, Nature Genetics.
[72] M. Buchwald,et al. Is Fanconi anemia caused by a defect in the processing of DNA damage? , 1998, Mutation research.
[73] G. Evans,et al. A trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias , 1992, Nature Genetics.
[74] A. Zelenetz,et al. Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). , 1995, Blood.
[75] D. Leprince,et al. The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[76] R. Treisman,et al. The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.
[77] Michael L. Cleary,et al. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.
[78] R. Krumlauf,et al. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. , 1995, Blood.